| Name | Title | Contact Details |
|---|
Duck Creek Technologies is a prominent provider of core system solutions for the property and casualty (P&C) and general insurance sectors. Founded by insurance experts, the company specializes in cloud-based technology that empowers P&C businesses to innovate and achieve significant results. Duck Creek focuses on delivering modern, flexible solutions that help insurance carriers stand out in a competitive market. The company offers a suite of low-code SaaS core systems tailored for the insurance industry. Key products include Duck Creek Policy, a comprehensive policy administration system that manages the entire policy lifecycle, and Duck Creek OnDemand, an enterprise software-as-a-service solution designed to help carriers respond to market changes swiftly. Duck Creeks customers are recognized as some of the most innovative in the industry, leveraging the companys technology to drive transformation. With over 1,200 employees across 12 offices in five countries, Duck Creek has received accolades for its strong company culture and growth. It is listed on NASDAQ under the ticker symbol DCT and actively maintains a partner ecosystem to enhance its offerings and support its clients success.
Brodock Press Inc is a Utica, NY-based company in the Business Services sector.
At enGene, we are at the vanguard of a new era in genetic medicine: Our novel Dually Derivatized Oligochitosan® (DDX) gene delivery platform is designed to enable localized delivery of multiple gene cargos, including RNA and DNA, directly to mucosal tissues and other organs — potentially overcoming the limitations of viral-based gene therapies and advancing gene therapy beyond rare genetic diseases into the mainstream of clinical practice. Our breakthrough Dually Derivatized Oligochitosan® (DDX) platform opens possibilities for streamlining the use of genetic medicines in the treatment of serious diseases, especially diseases afflicting mucosal tissues. Our lead product candidate, EG-70 (detalimogene voraplasmid), is a non-viral immunotherapy in development to treat non-muscle invasive bladder cancer (NMIBC), a disease with a significant patient burden, high clinical needs, and massive healthcare system economic impact. Based on its preliminary efficacy and safety profile and ease of administration by urologists, EG-70, which is currently in a pivotal trial, can potentially benefit patients across a wide variety of clinical settings. As enGeneers, we are boldly focused on patients needs. We are a team of passionate experts with extensive experience in drug development and commercialization across oncology, respiratory, and several other therapeutic areas. Nasdaq: ENGN
Sure-Response, Inc. is an independently owned and operated manufacturer and dealer specializing in staff communications and notification needs for the healthcare, retail and hospitality markets. Sure-Response provides unique product offerings from both our own proprietary line of products as well as partnerships formed with other manufacturers. By focusing on providing commercial grade hand held two-way radios that improves staff to staff communication, we have established our own brand in two-way radio market niches. Our company was founded in 2008 to not only to develop proprietary staff to staff communications tools but also to address the demand from pager to radio while combining with the nursing call system to improve patient safety and care. Our Radio Integration System allows for alarm notifications to come across our many brands of digital and analog radios, enabling staff to communicate efficiently thus eliminating the need for overhead paging. This invention improves the patients safety in senior care facilities. Now staff can communicate effectively while minimizing the number of devices they have to carry.
Schostak Brothers is a Southfield, MI-based company in the Business Services sector.